President, Chief Executive Officer & Director Dr. Brian Lian is an Independent Director at Seelos Therapeutics, Inc. and a President, Chief Executive Officer & Director at Viking Therapeutics, Inc.

Discover why Altimmune (ALT) and Viking Therapeutics (VKTX) are top picks for high-risk investors. Click here to read my most ...

As an Amazon Associate, we earn from qualifying purchases. TweakTown may also earn commissions from other affiliate partners at no extra cost to you. TL;DR: Lian Li's 011D Mini V2 case ...

As an Amazon Associate, we earn from qualifying purchases. TweakTown may also earn commissions from other affiliate partners at no extra cost to you. TL;DR: Lian Li’s Lancool 4 PC case features ...

A top-level executive departure at a rival juiced the biotech's shares. Viking is pushing hard in its development of a weight-loss drug. That rival is Novo Nordisk, which announced that its ...

Moderate dilution risk offset by potential partnerships or upside from trial success. Viking Therapeutics, Inc. (NASDAQ:VKTX) is a reasonably de-risked high potential play in obesity treatments.

A major C-suite change at a potential competitor was a key factor behind the rise of Viking Therapeutics (NASDAQ ... which announced that its current CEO Lars Jørgensen is to vacate his position.

A live webcast of the Jefferies presentation may be accessed via a link on the Viking Therapeutics website in the Investors & Media section under Webcasts. Additionally, a replay of the webcast ...

This is the Denmark-based pharmaceutical company that vaulted to prominence earlier this decade when its Wegovy became the first GLP-1 drug approved for obesity by the U.S. Food and Drug ...

ABU DHABI, UAE, May 28, 2025 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering therapies that target the innate immune system, announces that CEO Dr. David ...